These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3756399)

  • 1. Does sucrose damage kidneys?
    Li MK; Kavanagh JP; Prendiville V; Buxton A; Moss DG; Blacklock NJ
    Br J Urol; 1986 Aug; 58(4):353-7. PubMed ID: 3756399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
    Huang HS; Ma MC; Chen CF; Chen J
    Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis.
    Balla AA; Salah AM; Abdalmotaal E; Hoppe B; Bongartz D; Kessler T; Hesse A
    World J Urol; 1998; 16(6):413-6. PubMed ID: 9870291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary factors of kidney stone formation in patients with Crohn's disease.
    Böhles H; Beifuss OJ; Brandl U; Pichl J; Akçetin Z; Demling L
    Klin Wochenschr; 1988 Feb; 66(3):87-91. PubMed ID: 3352194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-carbon oxalogenesis compared in recurrent calcium oxalate stone formers and normal subjects.
    McWhinney BC; Nagel SL; Cowley DM; Brown JM; Chalmers AH
    Clin Chem; 1987 Jul; 33(7):1118-20. PubMed ID: 3594837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyl-beta-D-glucosaminidase excretion in calcium oxalate stone patients and its relation to the risk of stone formation.
    Winter P; Ganter K; Heimbach D; Hesse A
    Scand J Urol Nephrol; 1996 Dec; 30(6):439-43. PubMed ID: 9008022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of nifedipine on kidney output of calcium, oxalic acid, and saturation of urinary calcium oxalate].
    Pupek-Musialik D; Głuszek J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):74-5. PubMed ID: 1845698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

  • 13. Seasonal variation in urinary excretion of calcium, oxalate, magnesium and phosphate on free and standard mineral diet in men with urolithiasis.
    Juuti M; Heinonen OP; Alhava EM
    Scand J Urol Nephrol; 1981; 15(2):137-41. PubMed ID: 7330607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A; Marshall RW; Cochran M
    Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.